CA2598207A1 - Derives de chromane substitues, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation - Google Patents
Derives de chromane substitues, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation Download PDFInfo
- Publication number
- CA2598207A1 CA2598207A1 CA002598207A CA2598207A CA2598207A1 CA 2598207 A1 CA2598207 A1 CA 2598207A1 CA 002598207 A CA002598207 A CA 002598207A CA 2598207 A CA2598207 A CA 2598207A CA 2598207 A1 CA2598207 A1 CA 2598207A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- hydroxy
- groups
- general formula
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005017301.2 | 2005-04-14 | ||
DE102005017301A DE102005017301A1 (de) | 2005-04-14 | 2005-04-14 | Substituierte Chromanderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
PCT/EP2006/003780 WO2006108711A1 (fr) | 2005-04-14 | 2006-04-13 | Derives de chromane substitues, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2598207A1 true CA2598207A1 (fr) | 2006-10-19 |
Family
ID=36617258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002598207A Abandoned CA2598207A1 (fr) | 2005-04-14 | 2006-04-13 | Derives de chromane substitues, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1869013A1 (fr) |
JP (1) | JP2008535889A (fr) |
CN (1) | CN101160305A (fr) |
CA (1) | CA2598207A1 (fr) |
DE (1) | DE102005017301A1 (fr) |
WO (1) | WO2006108711A1 (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
DE10215316C1 (de) * | 2002-04-02 | 2003-12-18 | Schering Ag | Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer |
KR20050109922A (ko) * | 2003-01-03 | 2005-11-22 | 베링거 인겔하임 파마슈티칼즈, 인코포레이티드 | 1-프로판올과 1-프로필아민 유도체 및 글루코코르티코이드리간드로서의 이들의 용도 |
GB0418045D0 (en) * | 2004-08-12 | 2004-09-15 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-04-14 DE DE102005017301A patent/DE102005017301A1/de not_active Withdrawn
-
2006
- 2006-04-13 WO PCT/EP2006/003780 patent/WO2006108711A1/fr not_active Application Discontinuation
- 2006-04-13 JP JP2008505845A patent/JP2008535889A/ja active Pending
- 2006-04-13 CN CNA2006800121531A patent/CN101160305A/zh active Pending
- 2006-04-13 EP EP06742670A patent/EP1869013A1/fr not_active Withdrawn
- 2006-04-13 CA CA002598207A patent/CA2598207A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101160305A (zh) | 2008-04-09 |
DE102005017301A1 (de) | 2006-10-19 |
JP2008535889A (ja) | 2008-09-04 |
WO2006108711A1 (fr) | 2006-10-19 |
EP1869013A1 (fr) | 2007-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100967277B1 (ko) | 퀴놀린 및 이소퀴놀린 유도체, 그의 제조 방법 및항염증제로서의 그의 용도 | |
US7417056B2 (en) | 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents | |
CA2586689C (fr) | Derives de quinoline et d'isoquinoline 5-substitues, procede permettant de les produire et leur utilisation comme agents anti-inflammatoires | |
CA2657006C (fr) | Benzyl amines, procede pour leur preparation et leur utilisation en tant qu'agents anti-inflammatoires | |
CA2586973A1 (fr) | Amino-alcools tricycliques, processus de synthese et utilisation comme anti-inflammatoires | |
US20070129359A1 (en) | Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents | |
US7880042B2 (en) | Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics | |
ES2301056T3 (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como agentes antiinflamatorios. | |
US20070015750A1 (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
US20070015761A1 (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
US20060167025A1 (en) | Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs | |
US20060084652A1 (en) | Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
US20080188666A1 (en) | Linear phenyl-substituted indazoles and indoles, a process for their production and their use as anti-inflammatory agents | |
CA2598207A1 (fr) | Derives de chromane substitues, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation | |
US20070129358A1 (en) | Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents | |
WO2010009814A1 (fr) | 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl) amino]-1-arylquinoline-2-ones, leur procédé de production et leur utilisation comme agents anti-inflammatoires | |
CA2598208A1 (fr) | Derives de tetrahydronaphthaline, procede pour les preparer, et leur utilisation en tant qu'inhibiteurs d'inflammation | |
WO2008055709A1 (fr) | Dérivés indoles et indazoles en tant qu'agents anti-inflammatoires | |
CA2598969A1 (fr) | Derives de 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocycloheptene-6-ole et composes apparentes comme inhibiteurs d'inflammation | |
US20080227820A1 (en) | Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents | |
EP1921068A1 (fr) | Dérivés d'indazole et d'indole comme agents anti-inflammatoires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |